Search

everythinglearnresearchcommunity

for

Search:↓

Skin health and diseases are closely linked to metabolic processes.

Higher vitamin D levels are linked to higher iron levels in Korean women without metabolic syndrome, but not in those with it.

People with hidradenitis suppurativa often have lower vitamin D levels, weaker hip bones, and altered bone metabolism markers.

Metabolic syndrome reduces effectiveness of hair loss treatment.

Combined oral contraceptives improve skin, hormone levels, and quality of life in women with PCOS.

Eating less can improve stem cell function and increase lifespan.

People with more than 11 skin tags, especially on the thigh, neck, or armpit, may have a higher chance of metabolic syndrome.

848 genes related to fat and metabolism are less active in people with Central Centrifugal Cicatricial Alopecia.

There's no clear link between female pattern hair loss, insulin resistance, and metabolic syndrome.

Male pattern baldness, especially the vertex type, could be an early sign of cardiovascular risk factors like high cholesterol and diabetes.

Oral contraceptives provide various health benefits beyond birth control, including managing menstrual issues, skin conditions, pain, and reducing the risk of certain cancers.

Systemic retinoids are effective for psoriasis but have side effects; benefits may outweigh risks, especially when reducing cancer risks from other treatments.

Men with a family history of hair loss are more likely to experience it themselves, especially if both parents have hair loss.

Metallic-glass coated needles reduce skin trauma and improve tattoo quality.

Baldness may indicate higher heart disease risk in men.

Women with PCOS have more insulin resistance and are more likely to have heart-related health issues, with insulin resistance being a bigger factor than β-cell problems.

Women with irregular periods have a higher risk of heart disease.

Taking 5-α reductase inhibitors for prostate enlargement or hair loss does not significantly raise the risk of erectile dysfunction.

Nanomaterials in biomedicine can improve treatments but may have risks like toxicity, needing more safety research.

Women with PCOS who had antiandrogenic treatment before pregnancy had fewer complications than those without treatment.

WomenCare helps predict PCOD risk in women to encourage early medical consultation.

GLP-1RA therapy may increase the risk of hair loss.

Hair loss from weight-loss treatments is usually temporary and reversible.

Cosmetics can contain harmful chemicals that may cause health issues.

Physical activity, height, and smoking affect prostate cancer risk.

Age, race, family history, and certain genetic factors increase prostate cancer risk.

Metformin effectively improves metabolic symptoms in women with PCOS, while alfacalcidiol does not have a significant impact.

People with hair loss have higher risk of high blood sugar and diabetes, and lower levels of a specific hormone.

Obese and lean women with PCOS have different symptoms and need different treatments.

Too much androgen can cause hair loss; finasteride may help.